GlassScriptPhysician profile
Anthony S Rossi
NPI 1811153737
$1,945.70
in general payments reported to CMS, 2019-2025
26 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $181 · 2021: $193 · 2022: $131 · 2023: $574 · 2024: $210 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.75 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $839.84 | 2019-2023 | Da Vinci Surgical System |
| Novo Nordisk INC | $213.73 | 2024-2025 | Wegovy |
| Smith+Nephew, INC. | $161.49 | 2020-2025 | Grafix Pl |
| Abiomed | $103.86 | 2020-2021 | |
| Ethicon US, LLC | $86.60 | 2019-2020 | |
| Ets Wound Care LLC | $82.53 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Penumbra, INC. | $44.00 | 2021-2024 | Penumbra System |
| Kci USA, INC. | $39.66 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $38.53 | 2022 | |
| Cashflow Solutions, LLC | $30.38 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Abbvie INC. | $29.00 | 2025 | |
| Baxter Healthcare | $28.20 | 2023 | Tisseel |
| Astrazeneca Pharmaceuticals LP | $26.43 | 2025 | Imfinzi |
| Pharmaessentia USA Corporation | $24.76 | 2025 | Besremi |
| Caris Mpi, INC. | $22.76 | 2025 | Mi Cancer Seek |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $20.59 | 2024 | Sir-Spheres Microspheres |
| Pharmacosmos Therapeutics INC. | $20.00 | 2021 | |
| Kerecis Limited | $19.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mimedx Group, INC. | $17.77 | 2025 | |
| Teleflex LLC | $17.19 | 2023 | Titan Sgs Standard Gastric Stapler |
| Novartis Pharmaceuticals Corporation | $16.80 | 2022 | |
| Puma Biotechnology, INC. | $13.97 | 2021 | |
| Dilon Technologies, INC. | $13.64 | 2025 | Hemoblast Bellows |
| Covidien LP | $12.23 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.05 | 2020 | |
| Mvp Orthopedics INC | $9.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Rossi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.